Israel's BrainStorm to begin advanced trial for ALS stem cell treatment

TEL AVIV, Dec 19 (Reuters) - Israel's BrainStorm Cell

Therapeutics said it is proceeding to a Phase 3

clinical trial for its adult stem cell treatment in patients

with amyotrophic lateral sclerosis (ALS).

Read more